US · Healthcare

Grown Rogue International Inc (GRUSF)

Drug Manufacturers - Specialty & Generic

Grown Rogue International Inc (GRUSF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for GRUSF

P/E ratio

18.00

Grown Rogue International Inc (GRUSF) — FAQ

What is GRUSF's P/E ratio?

The price-to-earnings (P/E) ratio for Grown Rogue International Inc (GRUSF) is 18.00 (data as of 2026-05-23).

Does Grown Rogue International Inc pay a dividend?

Dividend yield is not available in the current snapshot for Grown Rogue International Inc (GRUSF). Check the MyAverix Finance app for the latest dividend data.

What sector is Grown Rogue International Inc in?

Grown Rogue International Inc (GRUSF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is GRUSF listed on?

GRUSF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)